Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

François Raffi, Abdel G. Babiker, Laura Richert, Jean Michel Molina, Elizabeth C. George, Andrea Antinori, Jose R. Arribas, Jesper Grarup, Fleur Hudson, Christine Schwimmer, Juliette Saillard, Cédrick Wallet, Per O. Jansson, Clotilde Allavena, Remko Van Leeuwen, Jean François Delfraissy, Stefano Vella, Geneviève Chêne, Anton Pozniak

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial'. Together they form a unique fingerprint.

Medicine & Life Sciences